A retrospective study of neoadjuvant FOLFIRINOX in unresectable or borderline-resectable locally advanced pancreatic adenocarcinoma
Pre-publication versions of this article are available by contacting email@example.com.
|14 Nov 2011||Submitted||Original manuscript|
|27 Dec 2011||Reviewed||Reviewer Report - Paula Ghaneh|
|2 Jan 2012||Reviewed||Reviewer Report - Thierry Conroy|
|17 Feb 2012||Author responded||Author comments - Peter Hosein|
|Resubmission - Version 2|
|17 Feb 2012||Submitted||Manuscript version 2|
|1 Mar 2012||Reviewed||Reviewer Report - Thierry Conroy|
|7 Mar 2012||Reviewed||Reviewer Report - Paula Ghaneh|
|10 May 2012||Author responded||Author comments - Peter Hosein|
|Resubmission - Version 3|
|10 May 2012||Submitted||Manuscript version 3|
|29 May 2012||Editorially accepted|
|29 May 2012||Article published||10.1186/1471-2407-12-199|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting firstname.lastname@example.org.
You can find further information about the peer review system here.